Phorbiplatin, First Platinum Antitumor Prodrug Controllably Activated by Red Light (IMAGE)
Caption
The controllable activation property and superior antitumor activity of phorbiplatin significantly contributes to the development of photoactivatable anticancer prodrugs, especially Pt(IV) prodrugs that can be activated by red light, to reduce the adverse effects and conquer drug resistance of traditional platinum chemotherapy.
Credit
City University of Hong Kong
Usage Restrictions
Image can only be used with appropriate caption or credit.
License
Licensed content